1297 related articles for article (PubMed ID: 19342621)
1. Myeloid-derived suppressor cells: linking inflammation and cancer.
Ostrand-Rosenberg S; Sinha P
J Immunol; 2009 Apr; 182(8):4499-506. PubMed ID: 19342621
[TBL] [Abstract][Full Text] [Related]
2. Myeloid-derived suppressor cells: more mechanisms for inhibiting antitumor immunity.
Ostrand-Rosenberg S
Cancer Immunol Immunother; 2010 Oct; 59(10):1593-600. PubMed ID: 20414655
[TBL] [Abstract][Full Text] [Related]
3. Prostaglandin E2 promotes tumor progression by inducing myeloid-derived suppressor cells.
Sinha P; Clements VK; Fulton AM; Ostrand-Rosenberg S
Cancer Res; 2007 May; 67(9):4507-13. PubMed ID: 17483367
[TBL] [Abstract][Full Text] [Related]
4. Proinflammatory S100 proteins regulate the accumulation of myeloid-derived suppressor cells.
Sinha P; Okoro C; Foell D; Freeze HH; Ostrand-Rosenberg S; Srikrishna G
J Immunol; 2008 Oct; 181(7):4666-75. PubMed ID: 18802069
[TBL] [Abstract][Full Text] [Related]
5. Myeloid-Derived Suppressor Cells: Immune-Suppressive Cells That Impair Antitumor Immunity and Are Sculpted by Their Environment.
Ostrand-Rosenberg S; Fenselau C
J Immunol; 2018 Jan; 200(2):422-431. PubMed ID: 29311384
[TBL] [Abstract][Full Text] [Related]
6. Inflammation enhances myeloid-derived suppressor cell cross-talk by signaling through Toll-like receptor 4.
Bunt SK; Clements VK; Hanson EM; Sinha P; Ostrand-Rosenberg S
J Leukoc Biol; 2009 Jun; 85(6):996-1004. PubMed ID: 19261929
[TBL] [Abstract][Full Text] [Related]
7. Myeloid-Derived Suppressor Cells: Critical Cells Driving Immune Suppression in the Tumor Microenvironment.
Parker KH; Beury DW; Ostrand-Rosenberg S
Adv Cancer Res; 2015; 128():95-139. PubMed ID: 26216631
[TBL] [Abstract][Full Text] [Related]
8. Cross-talk between myeloid-derived suppressor cells (MDSC), macrophages, and dendritic cells enhances tumor-induced immune suppression.
Ostrand-Rosenberg S; Sinha P; Beury DW; Clements VK
Semin Cancer Biol; 2012 Aug; 22(4):275-81. PubMed ID: 22313874
[TBL] [Abstract][Full Text] [Related]
9. Regulating the suppressors: apoptosis and inflammation govern the survival of tumor-induced myeloid-derived suppressor cells (MDSC).
Ostrand-Rosenberg S; Sinha P; Chornoguz O; Ecker C
Cancer Immunol Immunother; 2012 Aug; 61(8):1319-25. PubMed ID: 22546994
[TBL] [Abstract][Full Text] [Related]
10. Hampering immune suppressors: therapeutic targeting of myeloid-derived suppressor cells in cancer.
Albeituni SH; Ding C; Yan J
Cancer J; 2013; 19(6):490-501. PubMed ID: 24270348
[TBL] [Abstract][Full Text] [Related]
11. Reduced inflammation in the tumor microenvironment delays the accumulation of myeloid-derived suppressor cells and limits tumor progression.
Bunt SK; Yang L; Sinha P; Clements VK; Leips J; Ostrand-Rosenberg S
Cancer Res; 2007 Oct; 67(20):10019-26. PubMed ID: 17942936
[TBL] [Abstract][Full Text] [Related]
12. Myeloid-derived suppressor cells down-regulate L-selectin expression on CD4+ and CD8+ T cells.
Hanson EM; Clements VK; Sinha P; Ilkovitch D; Ostrand-Rosenberg S
J Immunol; 2009 Jul; 183(2):937-44. PubMed ID: 19553533
[TBL] [Abstract][Full Text] [Related]
13. Myeloid-derived suppressor cells in transplantation and cancer.
Ochando JC; Chen SH
Immunol Res; 2012 Dec; 54(1-3):275-85. PubMed ID: 22535241
[TBL] [Abstract][Full Text] [Related]
14. Adjuvants and myeloid-derived suppressor cells: enemies or allies in therapeutic cancer vaccination.
Fernández A; Oliver L; Alvarez R; Fernández LE; Lee KP; Mesa C
Hum Vaccin Immunother; 2014; 10(11):3251-60. PubMed ID: 25483674
[TBL] [Abstract][Full Text] [Related]
15. Myeloid-derived suppressor cell activation by combined LPS and IFN-gamma treatment impairs DC development.
Greifenberg V; Ribechini E; Rössner S; Lutz MB
Eur J Immunol; 2009 Oct; 39(10):2865-76. PubMed ID: 19637228
[TBL] [Abstract][Full Text] [Related]
16. Proteomic pathway analysis reveals inflammation increases myeloid-derived suppressor cell resistance to apoptosis.
Chornoguz O; Grmai L; Sinha P; Artemenko KA; Zubarev RA; Ostrand-Rosenberg S
Mol Cell Proteomics; 2011 Mar; 10(3):M110.002980. PubMed ID: 21191032
[TBL] [Abstract][Full Text] [Related]
17. Myeloid-derived suppressor cells in inflammation: uncovering cell subsets with enhanced immunosuppressive functions.
Bronte V
Eur J Immunol; 2009 Oct; 39(10):2670-2. PubMed ID: 19757440
[TBL] [Abstract][Full Text] [Related]
18. T cells conditioned with MDSC show an increased anti-tumor activity after adoptive T cell based immunotherapy.
Raber PL; Sierra RA; Thevenot PT; Shuzhong Z; Wyczechowska DD; Kumai T; Celis E; Rodriguez PC
Oncotarget; 2016 Apr; 7(14):17565-78. PubMed ID: 27007050
[TBL] [Abstract][Full Text] [Related]
19. Cancer-expanded myeloid-derived suppressor cells induce anergy of NK cells through membrane-bound TGF-beta 1.
Li H; Han Y; Guo Q; Zhang M; Cao X
J Immunol; 2009 Jan; 182(1):240-9. PubMed ID: 19109155
[TBL] [Abstract][Full Text] [Related]
20. Myeloid-derived suppressor cells attenuate TH1 development through IL-6 production to promote tumor progression.
Tsukamoto H; Nishikata R; Senju S; Nishimura Y
Cancer Immunol Res; 2013 Jul; 1(1):64-76. PubMed ID: 24777249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
